You can read our Premium News Service in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.
29 October 2021
Futura Medical has appointed former Boots executive Andrew Unitt to its board as a non-executive director with effect from 1 January 2022.
8 October 2021
Futura Medical has appointed Jeff Needham – former executive vice president and president of Consumer Self-Care Americas (CSCA) at Perrigo – to its board as a non-executive director.
28 September 2021
Futura Medical has licensed its topical erectile-dysfunction product MED3000 to Labatec Pharma in the Gulf region as well as Iraq, Jordan and Lebanon.
3 September 2021
Futura Medical has announced a collaboration to commercialise its topical erectile-dysfunction product MED3000 in Brazil and Mexico.
3 May 2021
Futura Medical’s MED3000 topical gel for erectile dysfunction has now been certified as a Class IIb medical device in the European Union. The company told OTCToolbox it was "in discussions with a number of parties" about marketing and distribution rights.
15 April 2021
Futura Medical has reported its annual results, and Alliance Pharma is losing a non-executive director.
25 March 2021
Futura Medical’s MED3000 medical device for erectile-dysfunction has moved a step closer to a launch in the European Union.
4 March 2021
Bayer has signed a distribution deal in Egypt, Futura Medical has announced a collaboration in China and South-East Asia, Ipsen has released financial results, and the US Consumer Healthcare Products Association (CHPA) has three new member companies.